3349
COSMOS Pharmaceutical Corporation
コスモス薬品
- Industry
- Retail Trade
- Market
- Prime
- Accounting standards
- Japanese GAAP
- Consolidation basis
- Consolidated
Notes
- Stock adjustmentsSep 1, 2024 Stock split 1 share → 2 shares
Key metrics
Revenue(million JPY)
May 2022
755,414
May 2023
827,697
May 2024
964,989
May 2025
1,011,390
May 2026
1,099,583
Operating profit(million JPY)
May 2022
29,796
May 2023
30,128
May 2024
31,501
May 2025
40,404
May 2026
42,353
Operating profit margin(%)
May 2022
3.94
May 2023
3.64
May 2024
3.26
May 2025
3.99
May 2026
3.85
Profit before tax(million JPY)
May 2022
33,048
May 2023
32,773
May 2024
33,719
May 2025
42,372
May 2026
44,218
Profit(million JPY)
May 2022
23,155
May 2023
23,797
May 2024
24,454
May 2025
30,978
May 2026
32,046
Total assets(million JPY)
May 2022
363,052
May 2023
420,967
May 2024
476,546
May 2025
524,755
May 2026
596,485
Cash and cash equivalents(million JPY)
May 2022
37,362
May 2023
45,928
May 2024
52,301
May 2025
57,038
May 2026
53,241
Cash flows from operating activities(million JPY)
May 2022
32,194
May 2023
54,434
May 2024
55,175
May 2025
52,467
May 2026
58,790
Cash flows from investing activities(million JPY)
May 2022
-43,717
May 2023
-49,113
May 2024
-57,329
May 2025
-55,448
May 2026
-81,903
Cash flows from financing activities(million JPY)
May 2022
-6,222
May 2023
3,245
May 2024
8,527
May 2025
7,717
May 2026
19,315
Return on equity(%)
May 2022
12.8
May 2023
11.9
May 2024
11.1
May 2025
12.7
May 2026
11.8
Equity ratio(%)
May 2022
52.5
May 2023
50.1
May 2024
48.6
May 2025
49.1
May 2026
47.6
Earnings per share(JPY per share)
May 2022
292.38
May 2023
300.48
May 2024
308.61
May 2025
390.86
May 2026
404.33
Net assets per share(JPY per share)
May 2022
2,405.46
May 2023
2,665.13
May 2024
2,920.13
May 2025
3,248.45
May 2026
3,579.49
Dividend per share(JPY per share)
May 2022
40
May 2023
50
May 2024
60
May 2025
70
May 2026
82
Payout ratio(%)
May 2022
13.68
May 2023
16.64
May 2024
19.44
May 2025
17.91
May 2026
20.28
Disclaimer
The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.
The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.